FIA
PLXP

FNY Investment Advisers’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

FNY Investment Advisers’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,987
Closed -$57K – 894
2021
Q3 		$57K Buy
+2,987
New +$52.2K 0.03% 323

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return

FNY Investment Advisers's PLXP Position: Q4 2021 in Review

FNY Investment Advisers sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2021, closing a stake of 2,987 shares — an estimated $57K sold.

FNY Investment Advisers first reported a position in PLXP in Q3 2021 and held it in 1 quarter. The position peaked at $57K in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • FNY Investment Advisers reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 2,987 PLx Pharma Inc. Common Stock shares in Q4 2021, an estimated $57K.
  • FNY Investment Advisers first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • FNY Investment Advisers's PLx Pharma Inc. Common Stock position peaked at $57K in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2021.

Based on FNY Investment Advisers's 13F filing for Q4 2021, filed 10 Jan 2022.